Tirzepatide – Mounjaro 2.5mg/1 Vial

Take control of your type 2 diabetes with Tirzepatide (Mounjaro) 2.5mg, a cutting-edge GLP-1/GIP receptor agonist designed to improve glycemic control and support metabolic health. This single-dose vial contains 2.5mg of tirzepatide, the active ingredient approved by the FDA for adults with type 2 diabetes, and is typically used in combination with diet and exercise.

Mounjaro offers dual hormone receptor activity, mimicking both GLP-1 and GIP to regulate blood sugar levels more effectively than traditional single-pathway treatments. Clinical studies have shown that tirzepatide significantly lowers A1C levels and supports weight loss in many patients.

Key Features:

• Active Ingredient: Tirzepatide 2.5mg per vial

• Dual Mechanism: Targets GLP-1 and GIP receptors

• Indication: Adjunct to diet and exercise for adults with type 2 diabetes

• Benefits: Improved blood sugar control, potential weight reduction

• Format: Single-dose vial for subcutaneous injection

• Storage: Refrigerate at 2°C to 8°C (36°F to 46°F). Do not freeze.